Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.
To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32
pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance
analysis (BIA) as a proven tool for nutritional investigation in patients with chronic
disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in
several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive
pulmonary disease lung cancer and pancreatic cancer.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
nutritional status presented by phase angle
helmut oettle, MD
Germany: Federal Institute for Drugs and Medical Devices